New Drugs Approved In November

Shutterstock photo

(RTTNews.com) - The process of drug development is challenging. Some drugs pass the FDA muster easily, while some face a host of hurdles before getting the official stamp of approval.

So far, 40 novel drugs have been approved for this year, compared to just 22 in 2016. Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.

Let's take a look at the drugs that crossed the regulatory finish line in November.


This article appears in: World Markets , Stocks , Politics
Referenced Symbols: AZN ,

More from RTT News


See headlines for AZN

Research Brokers before you trade

Want to trade FX?